← Eichor
Study identifier: NCT06592924 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Condition: Prostate Cancer (Adenocarcinoma)  ·  Sponsor: Canadian Cancer Trials Group

PhasePhase 3
Planned participants830
Who can joinMale, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study is being done to answer the following question: can the chance of prostate cancer growing or spreading be lowered by adding a drug to the usual combination of drugs? This study would like to find out if this approach is better or worse than the usual approach for prostate cancer. The usual approach for patients who are not in a study is hormone treatment with Androgen Deprivation Therapy (ADT) and Androgen-Receptor Pathway Inhibitor (ARPI).

This description comes directly from the study's public registry record.

Talk to the study team

Mariam Jafri  ·  613-533-6430  ·  mjafri@ctg.queensu.ca

Wendy Parulekar  ·  613-533-6430  ·  wparulekar@ctg.queensu.ca

Always discuss trial participation with your own doctor first.

Locations (395)

Anchorage Associates in Radiation MedicineAnchorage, Alaska, United StatesRecruiting
Alaska Breast Care and Surgery LLCAnchorage, Alaska, United StatesRecruiting
Alaska Oncology and Hematology LLCAnchorage, Alaska, United StatesRecruiting
Alaska Women's Cancer CareAnchorage, Alaska, United StatesRecruiting
Katmai Oncology GroupAnchorage, Alaska, United StatesRecruiting
Providence Alaska Medical CenterAnchorage, Alaska, United StatesRecruiting
Fairbanks Memorial HospitalFairbanks, Alaska, United StatesRecruiting
Cancer Center at Saint Joseph'sPhoenix, Arizona, United StatesRecruiting
Kaiser Permanente-AnaheimAnaheim, California, United StatesRecruiting
Mission Hope Medical Oncology - Arroyo GrandeArroyo Grande, California, United StatesRecruiting
Kaiser Permanente-Baldwin ParkBaldwin Park, California, United StatesRecruiting
Kaiser Permanente-BellflowerBellflower, California, United StatesRecruiting

+ 383 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06592924